Updated March 3, 2008
Pfizer to Acquire Drug Development Company Serenex
Post a comment
Print this storyE-mail story
Share
Durham, N.C. —
Durham-based company is focused on fighting cancer with technology developed at Duke University. Financial backers include Intersouth. Serenex had raised $81M in venture capital. Copyright 2013 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Log in or upgrade to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
